Medi N Research has possesed microbiome’s proprietary patented material (radiation resistant microorganism “Deinococcus radiodurans EPS”, DeinoPol) and formulation technology, and is conducting R&D for cosmetic materials based on this technology. We plan to launch 3 types of the new basic skin care product (toner, serum, and cream) using DeinoPol as a raw material in the first half of 2023.
Starting with the launch of DeinoPol cosmetics, we are expanding our business with the ultimate goal of entering the quasi-drug market and industrializing functional materials.
Medi N Research will do its best to become a leader in the domestic and foreign markets by strengthening R&D in the microbiome field and gaining competitiveness.
